ACHL

Achilles Therapeutics

Delisted

ACHL was delisted on the 20th of March, 2025.

22 hedge funds and large institutions have $24.8M invested in Achilles Therapeutics in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$3.54M
2 +$20.4K
3 +$12.7K
4
Morgan Stanley
Morgan Stanley
New York
+$7.65K
5
AIM
Arcadia Investment Management
Michigan
+$3.06K

Top Sellers

1 -$904K
2 -$616K
3 -$53.5K
4
Citadel Advisors
Citadel Advisors
Florida
-$50K
5
Renaissance Technologies
Renaissance Technologies
New York
-$45.5K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$11.3M
2
$4.18M
3
$2.44M
4
$1.64M
5
$1.53M
6
$1.47M
7
$770K
8
$651K
9
$429K
10
$255K
11
$22.8K
12
$22K
13
$21.7K
14
$20.4K
15
$16.8K
16
$12.7K
17
$10.4K
18
$10.2K
19
$4.57K
20
$3.06K
21
$140
22
$15
23
24
25